GlobalData
GlobalData

Medical Devices

In vitro diagnostics to help cancer patients in Japan by supporting personalized oncology medicine, says GlobalData

Japan’s personalized medicine service provider Riken Genesis has recently collaborated with cancer intelligence firm C2i Genomics to make AI-powered whole-genome minimal residual disease (MRD) cancer detection technology “C2inform MRD” available across Japan. Such in vitro diagnostics (IVD)-oncology solutions help physicians not only in precise diagnosis but also aid in prescribing rational medications. Thus, the exceeding […]
Read more

Nanoparticle-based deep brain stimulation therapy to revolutionize neurological disease treatment in South Korea, says GlobalData

The treatment of neurodegenerative diseases such as Parkinson’s or Alzheimer’s has been a longstanding challenge for medical researchers. However, researchers at South Korea’s Pohang University of Science and Technology have developed a new nanoparticle-based technique to administer electrical stimulation to the brain without the use of implanted electrodes. This has the potential to establish a […]
Read more

GlobalData forecasts Australia heart valve market to reach $50 million in 2030

The sedentary lifestyle and unhealthy choices of the geriatric population in Australia will continue to put them at risk of cardiovascular diseases, especially after the COVID-19 pandemic. Consequently, the rising burden of these diseases will likely increase the demand for minimally invasive procedures, such as Anteris Technologies’ DurAVR transcatheter heart valve. Against this backdrop, the […]
Read more

COVID-19 to drive demand for extracorporeal membrane oxygenation devices market, says GlobalData

The global extracorporeal membrane oxygenation (ECMO) devices market is expected to experience significant growth over the next few years, driven by increasing investment in healthcare infrastructure, growing awareness of ECMO therapy, and the rising adoption of ECMO devices in emerging markets. The market is also likely to be driven by the ongoing COVID-19 pandemic, which […]
Read more

Future of diagnosing and monitoring nonalcoholic fatty liver disease/nonalcoholic steatohepatitis could be noninvasive, says GlobalData

Liver fibrosis is a key characteristic that represents the severity of liver illnesses and is an important factor that helps forecast the progression of liver disorders toward cirrhosis. Although liver biopsies are currently considered to be the gold standard for the diagnosis and histological assessment of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH), they are not […]
Read more

3D printing in medical devices set to become $4 billion industry by 2026, forecasts GlobalData

3D printing complements traditional manufacturing by offering new opportunities for personalization and small-batch production of complicated parts. In medical devices, this allows for customized devices uniquely suited to patients, improving fit, comfort, and outcomes while reducing the risk of complications. Given its advantages, the medical 3D printing market is forecast to grow from just over […]
Read more

Transcarotid artery revascularization set to overtake endarterectomy procedures, says GlobalData

Transcarotid artery revascularization (TCAR) allows for better outcomes in patients with high-risk factors, such as advanced age, previous neck surgery, or radiation therapy. Additionally, it has been shown to have long-term effectiveness in preventing stroke. As a result, the minimally invasive TCAR technique is set to overtake the traditional carotid endarterectomy procedures, according to GlobalData, […]
Read more

Diagnostic imaging to drive image visualization solutions market in Japan, says GlobalData

Clinical images assist physicians in routine clinical practice. However, there is an increasing need for a single software/platform, which is compatible with multiple modalities such as CT, and MRI available through different vendors. Against this backdrop, Japan’s Canon Medical Systems Corp. received additional US FDA 510(k) approval for Vitrea Software Package, a vendor-agnostic multi-modality image […]
Read more

Ferronova nanotech image-guided therapy to drive new standards in cancer care in Australia, says GlobalData

Australian biotech startup Ferronova has recently secured A$11 million to advance its nanoparticle platform and help surgeons locate and remove complex gastrointestinal and brain tumors. International investment, coupled with government support, is expected to provide a solid foundation to accelerate research and advance nanotechnology frontiers in the treatment of all types of brain and gastric-esophageal […]
Read more
1 22 23 24 25 26 50